Skip to content
PulseMS
Log inJoin
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to reviewed research. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Research and community updates, newest first.#SymptomMgmtAI researchClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedSystematic reviewPeer review unconfirmed

Neuroprotective Activity of Curcumin in Animal Models

A systematic review found that curcumin showed neuroprotective activity in preclinical models of Alzheimer's, Parkinson's, multiple sclerosis, and amyotrophic lateral sclerosis. However, over 80% of positive findings from animal studies have not been replicated in humans.

What this does not proveThe findings are limited by incomplete formulation characterization, lack of CNS-exposure biomarkers in trials, and significant discrepancies between animal and human studies.
#Curcumin#DrugDeliverySystems#Neuroprotection#SymptomMgmtRelevant to Neurologist, Pharmacologist
View abstract on PubMedPMID 42797450AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedObservationalPeer review unconfirmed

Survey on Internet Use for MS Information Among Participants

An online survey involving 152 MS participants highlighted that 99% used the Internet to seek MS-related information, with 84% searching for medicine specifics. MS specialists were the most trusted source, but 54.4% had concerns regarding the quality of online information.

What this does not proveFindings are exploratory and drawn from a specific charity's engaged members, lacking a calculable response rate. They require validation in broader, more representative samples.
#EBV#SymptomMgmt#Wellness#DietNutritionRelevant to Neurologist, Immunologist
View abstract on PubMedPMID 42793465AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer review unconfirmed

Eating-Related Tendencies in Adults with Multiple Sclerosis

A study with 382 adults with multiple sclerosis identified distinct eating-related profiles. These profiles were categorized into five classes: low difficulties, moderate mixed tendencies, two emotional eating/restraint profiles, and dysregulated overeating. Higher self-management scores were observed in restraint-related profiles.

What this does not proveThe study does not establish clinical classification or treatment recommendations, and it merely serves as a basis for future research.
#DietNutrition#SymptomMgmt#Wellness#SelfManagementRelevant to Neurologist, Dietitian
View abstract on PubMedPMID 42796967AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedSystematic reviewPeer-reviewed

Mesenchymal Stem Cell Transplantation in Progressive Multiple Sclerosis: A Systematic Review

A systematic review assessed the efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis. It was identified as a correction to previous findings, indicating an update rather than new data.

What this does not proveThe study does not present new data on the efficacy or safety of the treatment, only correcting earlier findings without additional evidence.
#StemCellTherapy#Wellness#SymptomMgmt#ImmunologyRelevant to Neurologist, Immunologist
View abstract on PubMedPMID 42798841AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed

Physiotherapy Effects on Disability Improvement in People with MS

In a study involving 1430 individuals from the German MS Registry, physiotherapy (PT) was associated with an increased incidence of confirmed disability improvement (CDI) over up to 8 years, showing 16.3% improvement compared to 11.1% without PT.

What this does not proveThis study does not establish causation between PT and CDI, only association.
#Physiotherapy#DisabilityImprovement#SymptomMgmt#WellnessRelevant to Neurologist, Physical Therapist
View abstract on PubMedPMID 42790155AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studySystematic reviewPeer review unconfirmed

Telerehabilitation for Motor Recovery in Adults with Neurological Disorders

A systematic review found that telerehabilitation may improve walking and mobility in adults with neurological disorders, though results were imprecise and inconclusive. The evidence for overall motor functional recovery and daily living activities was also uncertain. Findings were based on data from 87 studies, including various neurological conditions, but showed wide confidence intervals indicating low certainty.

What this does not proveThe evidence is limited by small sample sizes, heterogeneity in conditions studied, and significant uncertainties about the true effectiveness and safety of the interventions.
#Telerehabilitation#MotorRecovery#SymptomMgmt#WellnessRelevant to Neurologist, Physical Therapist
View abstract on PubMedPMID 42793397AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed

Efficacy of Intranasal Nanoemulsions in Rats

In an animal study, an intranasal formulation of dimethyl fumarate (DMF) achieved maximum cerebrospinal fluid (CSF) concentrations of approximately 8 µg/mL within 2 hours of administration in rats. Additionally, the formulation was characterized by optimal physicochemical properties, including a mean particle size of about 170 nm.

What this does not proveThe study does not provide data from human clinical trials, so the findings are limited to animal models and cannot be directly applied to human treatment.
#DimethylFumarate#Nanoemulsion#CNSDelivery#SymptomMgmtRelevant to Neurologist, Pharmacologist
View abstract on PubMedPMID 42797343AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer review unconfirmed

Longitudinal Gut Microbiome Study in Relapsing-Remitting MS Patients

In a study of 29 treatment-naïve patients with relapsing-remitting multiple sclerosis (RRMS), gut microbiota composition and diversity remained stable over one year. While there was a trend indicating that worsening disability (measured by EDSS) correlated with increased microbiome instability, this did not reach statistical significance. Additionally, GFAP levels increased significantly, while NfL levels decreased and S100B levels remained unchanged.

What this does not proveThe study's exploratory analyses noted that significant associations found did not hold after adjustments for multiple testing. Moreover, the small sample size necessitates larger longitudinal studies to better understand these relationships.
#GutHealth#Disability#Biomarkers#SymptomMgmtRelevant to Neurologist, Immunologist
View abstract on PubMedPMID 42795661AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed

CAR-T Cell Therapy and Gut Microbiota Modulation in MS

Research suggests that CAR-T cells can effectively target and eliminate B cells in multiple sclerosis (MS). Additionally, the gut microbiota is found to play a significant role in immune system balance related to MS.

What this does not proveThe findings do not demonstrate clinical efficacy for CAR-T therapy in MS patients, nor do they clarify how gut microbiota modulation influences MS symptoms or progression.
#CARTCellTherapy#GutMicrobiota#SymptomMgmt#WellnessRelevant to Neurologist, Immunologist
View abstract on PubMedPMID 42793314AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer review unconfirmed

Long-term Disability Trends in Multiple Sclerosis: Observational Study of Human Patients

In a 10-year study involving 391 self-enrolled MS patients in the Netherlands, disabilities related to daily activities increased over time, while some aspects of disability related to environmental support improved. Other disabilities remained stable, and QoL scores showed no change.

What this does not proveThe study does not establish causation or the impact of interventions and may be subject to selection bias due to its self-enrolled cohort.
#SymptomMgmt#Wellness#HealthcareSupport#QualityOfLifeRelevant to Neurologist, HealthcarePolicy
View abstract on PubMedPMID 42799509AI summary of a published abstract. Not medical advice.